Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

MR-1 Fab' PEG shows promise in murine model of arthritis

June 20, 2011

Phase I data support safety and possible activity of Rheumavax in rheumatoid arthritis

June 20, 2011

Secukinumab reduces symptoms of active rheumatoid arthritis in clinical settings

June 15, 2011

Galapagos' GLPG-0634 enters phase II trial in rheumatoid arthritis

June 10, 2011

Galapagos discloses first-in-human data on GLPG-0634

June 10, 2011

Topline phase IIb data reported on vidofludimus in rheumatoid arthritis

June 9, 2011

BioMimetic Therapeutics completes enrollment in trial of Augment Rotator Cuff Graft

June 8, 2011

Azanin tablets are approved for additional indications in Japan

June 6, 2011

Recruitment begins in phase Ib Ampion trial in osteoarthritis of the knee

June 3, 2011

CrystalGenomics begins phase IIb trial of CG-100649 in osteoarthritis

June 2, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...